{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:51:33Z","timestamp":1791510693521,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["32622"],"award-info":[{"award-number":["32622"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020889","name":"Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["91041"],"award-info":[{"award-number":["91041"]}],"id":[{"id":"10.13039\/501100020889","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.lfs.2026.124716","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:07:23Z","timestamp":1790698043000},"page":"124716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Co-administration of empagliflozin and curcumin attenuates the development of MASLD by modulating lipid metabolism and adipose tissue browning in HFD-fed C57BL\/6J mice"],"prefix":"10.1016","volume":"405","author":[{"given":"Masoume","family":"Aliabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Taheripak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Nourbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Meshkani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lfs.2026.124716_bb0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124716_bb0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.lfs.2026.124716_bb0015","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.lfs.2026.124716_bb0020","first-page":"4","article-title":"A review of the therapeutic effects of polyphenols on non-alcoholic fatty liver disease: focus on oxidative stress","volume":"2","author":"Soleimani","year":"2024","journal-title":"Acta Biochim. Iran."},{"issue":"18","key":"10.1016\/j.lfs.2026.124716_bb0025","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.lfs.2026.124716_bb0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.lfs.2026.124716_bb0035","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2337\/dc18-0165","article-title":"Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT trial)","volume":"41","author":"Kuchay","year":"2018","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.lfs.2026.124716_bb0040","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/dom.15006","article-title":"Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue-specific insulin sensitivity in patients with early-stage type 2 diabetes with non-alcoholic fatty liver disease: a prospective randomized study","volume":"25","author":"Hiruma","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.lfs.2026.124716_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","article-title":"SGLT2 inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced obese mice","volume":"20","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.lfs.2026.124716_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/foods6100092","article-title":"Curcumin: a review of its effects on human health","volume":"6","author":"Hewlings","year":"2017","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.lfs.2026.124716_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imr.2018.07.004","article-title":"Efficacy of curcumin\/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials","volume":"8","author":"Mansour-Ghanaei","year":"2019","journal-title":"Integr. Med. Res."},{"issue":"1","key":"10.1016\/j.lfs.2026.124716_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12986-021-00625-5","article-title":"Dietary curcumin supplementation promotes browning and energy expenditure in postnatal overfed rats","volume":"18","author":"Zhu","year":"2021","journal-title":"Nutr. Metab."},{"issue":"2","key":"10.1016\/j.lfs.2026.124716_bb0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40200-026-02013-3","article-title":"Combination of empagliflozin with curcumin attenuates hepatic inflammation in high-fat diet-fed mice via macrophage polarization remodeling and NF-\u03baB modulation","volume":"25","author":"Aliabadi","year":"2026","journal-title":"J. Diabetes Metab. Disord."},{"issue":"2","key":"10.1016\/j.lfs.2026.124716_bb0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","article-title":"Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition","volume":"60","author":"Vallon","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2026.124716_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jnim.2018.05.001","article-title":"Utility of curcumin for the treatment of diabetes mellitus: evidence from preclinical and clinical studies","volume":"14","author":"Rivera-Manc\u00eda","year":"2018","journal-title":"J. Nutr. Intermed. Metab."},{"issue":"4","key":"10.1016\/j.lfs.2026.124716_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Med."},{"issue":"10","key":"10.1016\/j.lfs.2026.124716_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101476","article-title":"Curcumin inhibits age-related vascular changes in aged mice fed a high-fat diet","volume":"10","author":"Takano","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2026.124716_bb0090","series-title":"Thermogenic Fat: Methods and Protocols","first-page":"135","article-title":"Assessment of brown and beige adipose tissue activation in mice using PET\/CT imaging","author":"Chen","year":"2023"},{"issue":"1","key":"10.1016\/j.lfs.2026.124716_bb0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2026.124716_bb0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2026.124716_bb0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman\u2019s reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2026.124716_bb0110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0076-6879(90)86141-H","article-title":"Determination of carbonyl content in oxidatively modified proteins","volume":"186","author":"Levine","year":"1990","journal-title":"Methods Enzymol."},{"issue":"11","key":"10.1016\/j.lfs.2026.124716_bb0115","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1017\/S0007114521000490","article-title":"Curcumin induces mitochondrial biogenesis by increasing cyclic AMP levels via phosphodiesterase 4A inhibition in skeletal muscle","volume":"126","author":"Hamidie","year":"2021","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.lfs.2026.124716_bb0120","series-title":"Empagliflozin-Enhanced Antioxidant Defense Attenuates Lipotoxicity and Protects Hepatocytes by Promoting FoxO3a- and Nrf2-Mediated Nuclear Translocation via the CAMKK2\/AMPK Pathway","first-page":"799","volume":"11(5)","author":"Wang","year":"2022"},{"key":"10.1016\/j.lfs.2026.124716_bb0125","series-title":"Curcumin and Saroglitazar Attenuate Diet-induced Nonalcoholic Steatohepatitis by Activating the Nrf2 Pathway and Suppressing ERK1\/2 Signaling","first-page":"1015","volume":"27(8)","author":"Afarin","year":"2024"},{"issue":"5","key":"10.1016\/j.lfs.2026.124716_bb0130","first-page":"1091","article-title":"Role of lipids and lipid metabolism in the pathophysiology of NAFLD","volume":"76","author":"Fuchs","year":"2022","journal-title":"J. Hepatol."},{"issue":"15","key":"10.1016\/j.lfs.2026.124716_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/nu16152566","article-title":"Discovery of curcuminoids as pancreatic lipase inhibitors from medicine-and-food homology plants","volume":"16","author":"He","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2026.124716_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2023.03.011","article-title":"Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora","volume":"371","author":"Hao","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2026.124716_bb0145","first-page":"120","article-title":"Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice","volume":"28","author":"Xu","year":"2019","journal-title":"Mol. Metab."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526005254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526005254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:29:07Z","timestamp":1791509347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526005254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"alternative-id":["S0024320526005254"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124716","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-administration of empagliflozin and curcumin attenuates the development of MASLD by modulating lipid metabolism and adipose tissue browning in HFD-fed C57BL\/6J mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124716"}}